drugset / Trial / NCT03140423
Mupirocin-Iodophor ICU Decolonization Swap Out Trial
Phase 4
Completed
353323 enrolled
Harvard Pilgrim Health Care
Centers for Disease Control and Prevention · collabHospital Corporation of America · collabRush University · collabUniversity of California, Irvine · collabUniversity of Massachusetts, Amherst · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The Swap Out Trial is a cluster randomized controlled trial of HCA hospitals, evaluating the non-inferiority of two decolonization regimens: Arm 1 Routine Care: ICU nasal decolonization with mupirocin twice daily for 5 days in the context of chlorhexidine for daily bathing; Arm 2 Intervention: ICU nasal decolonization with iodophor twice daily for 5 days in the context of chlorhexidine for daily bathing Note: that enrolled "subjects" represents 137 individual HCA Hospitals (representing \~235 ICUs) that have been randomized.
Timeline
- Start
- 2017-05-01
- Primary completion
- 2023-11-06
- Completion
- 2023-11-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Iodophor | Unknown | 10 % | Intranasal |
| Comparator | Mupirocin | Small molecule | — | Intranasal |
| Comparator | Chlorhexidine | Small molecule | 2 % | Topical |